316 related articles for article (PubMed ID: 26936506)
1. Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models.
Karuppagounder SS; Alim I; Khim SJ; Bourassa MW; Sleiman SF; John R; Thinnes CC; Yeh TL; Demetriades M; Neitemeier S; Cruz D; Gazaryan I; Killilea DW; Morgenstern L; Xi G; Keep RF; Schallert T; Tappero RV; Zhong J; Cho S; Maxfield FR; Holman TR; Culmsee C; Fong GH; Su Y; Ming GL; Song H; Cave JW; Schofield CJ; Colbourne F; Coppola G; Ratan RR
Sci Transl Med; 2016 Mar; 8(328):328ra29. PubMed ID: 26936506
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor prolyl hydroxylase domain (PHD) inhibition after contusive spinal cord injury does not improve locomotor recovery.
Wei GZ; Saraswat Ohri S; Khattar NK; Listerman AW; Doyle CH; Andres KR; Karuppagounder SS; Ratan RR; Whittemore SR; Hetman M
PLoS One; 2021; 16(4):e0249591. PubMed ID: 33819286
[TBL] [Abstract][Full Text] [Related]
3. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.
Nangaku M; Izuhara Y; Takizawa S; Yamashita T; Fujii-Kuriyama Y; Ohneda O; Yamamoto M; van Ypersele de Strihou C; Hirayama N; Miyata T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2548-54. PubMed ID: 17932321
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways.
Siddiq A; Aminova LR; Troy CM; Suh K; Messer Z; Semenza GL; Ratan RR
J Neurosci; 2009 Jul; 29(27):8828-38. PubMed ID: 19587290
[TBL] [Abstract][Full Text] [Related]
5. Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases.
Cho EA; Song HK; Lee SH; Chung BH; Lim HM; Lee MK
J Cell Biochem; 2013 Apr; 114(4):864-73. PubMed ID: 23097160
[TBL] [Abstract][Full Text] [Related]
6. HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease.
Niatsetskaya Z; Basso M; Speer RE; McConoughey SJ; Coppola G; Ma TC; Ratan RR
Antioxid Redox Signal; 2010 Apr; 12(4):435-43. PubMed ID: 19659431
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.
Floyd ZE; Kilroy G; Wu X; Gimble JM
J Cell Biochem; 2007 Aug; 101(6):1545-57. PubMed ID: 17370314
[TBL] [Abstract][Full Text] [Related]
8. Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94.
Baek JH; Reiter CE; Manalo DJ; Buehler PW; Hider RC; Alayash AI
Biochim Biophys Acta; 2011; 1809(4-6):262-8. PubMed ID: 21558026
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α.
Ogle ME; Gu X; Espinera AR; Wei L
Neurobiol Dis; 2012 Feb; 45(2):733-42. PubMed ID: 22061780
[TBL] [Abstract][Full Text] [Related]
10. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation.
Martin F; Linden T; Katschinski DM; Oehme F; Flamme I; Mukhopadhyay CK; Eckhardt K; Tröger J; Barth S; Camenisch G; Wenger RH
Blood; 2005 Jun; 105(12):4613-9. PubMed ID: 15741220
[TBL] [Abstract][Full Text] [Related]
11. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin.
Zaman K; Ryu H; Hall D; O'Donovan K; Lin KI; Miller MP; Marquis JC; Baraban JM; Semenza GL; Ratan RR
J Neurosci; 1999 Nov; 19(22):9821-30. PubMed ID: 10559391
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis.
Neitemeier S; Dolga AM; Honrath B; Karuppagounder SS; Alim I; Ratan RR; Culmsee C
Cell Death Dis; 2016 May; 7(5):e2214. PubMed ID: 27148687
[TBL] [Abstract][Full Text] [Related]
13. Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line.
Aminova LR; Siddiq A; Ratan RR
Antioxid Redox Signal; 2008 Dec; 10(12):1989-98. PubMed ID: 18774900
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system.
Siddiq A; Ayoub IA; Chavez JC; Aminova L; Shah S; LaManna JC; Patton SM; Connor JR; Cherny RA; Volitakis I; Bush AI; Langsetmo I; Seeley T; Gunzler V; Ratan RR
J Biol Chem; 2005 Dec; 280(50):41732-43. PubMed ID: 16227210
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.
Souvenir R; Flores JJ; Ostrowski RP; Manaenko A; Duris K; Tang J
Transl Stroke Res; 2014 Feb; 5(1):118-27. PubMed ID: 24323731
[TBL] [Abstract][Full Text] [Related]
16. Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing.
Metzen E; Berchner-Pfannschmidt U; Stengel P; Marxsen JH; Stolze I; Klinger M; Huang WQ; Wotzlaw C; Hellwig-Bürgel T; Jelkmann W; Acker H; Fandrey J
J Cell Sci; 2003 Apr; 116(Pt 7):1319-26. PubMed ID: 12615973
[TBL] [Abstract][Full Text] [Related]
17. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
18. Deferasirox, a trivalent iron chelator, ameliorates neuronal damage in hemorrhagic stroke models.
Imai T; Tsuji S; Matsubara H; Ohba T; Sugiyama T; Nakamura S; Hara H; Shimazawa M
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jan; 394(1):73-84. PubMed ID: 32808069
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and mRNA expression of two key enzymes of hypoxia-sensing pathways in eastern oysters Crassostrea virginica (Gmelin): hypoxia-inducible factor α (HIF-α) and HIF-prolyl hydroxylase (PHD).
Piontkivska H; Chung JS; Ivanina AV; Sokolov EP; Techa S; Sokolova IM
Comp Biochem Physiol Part D Genomics Proteomics; 2011 Jun; 6(2):103-14. PubMed ID: 21106446
[TBL] [Abstract][Full Text] [Related]
20. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
Kasiganesan H; Sridharan V; Wright G
Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
